HMGB1/IL-17A Axis: an Important Mechanism for Myocardial Ischemia–reperfusion Injury

Xiaorong Hu,Xu Wang,Hong Jiang

DOI: https://doi.org/10.1016/j.ijcard.2014.04.021

IF: 4.039

2014-01-01

International Journal of Cardiology

Abstract:The most effective therapy after an acute myocardial infarction is the rapid restoration of blood flow by mechanical or pharmacological intervention [ [1] Hillis L.D. Lange R.A. Myocardial infarction and the open-artery hypothesis. N Engl J Med. 2006; 355: 2475-2477 Crossref PubMed Scopus (30) Google Scholar ]. The early reperfusion is critical for decreasing the size of myocardial infarct and improving the clinical outcome. Myocardial reperfusion therapy (such as thrombolysis and percutaneous coronary intervention) is the most optimal therapeutic strategy for acute myocardial infarction, which could preserve myocardial cell viability and keep myocardial function by reversing myocardial ischemia and protect against myocardial ischemia–reperfusion (I/R) injury, such as reducing infarct size, inhibiting the increase of myocardial enzymes and have been endorsed extensively in clinical practice [ [2] Takemura G. Nakagawa M. Kanamori H. et al. Benefits of reperfusion beyond infarction size limitation. Cardiovasc Res. 2009; 83: 269-276 Crossref PubMed Scopus (43) Google Scholar ]. However, the subsequent I/R injury may attenuate the therapeutic benefit. Although reperfusion therapy is essential for the survival of myocardial ischemic tissue, reperfusion itself could cause additional myocardial cellular injury. I/R could cause local myocardial inflammation, accompanying with apoptosis, which could result in myocardial cell damage [ [3] Frangoginis N.G. Smith C.W. Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002; 53: 31-47 Crossref PubMed Scopus (1714) Google Scholar ]. A growing body of evidence supports that inflammatory processes including leukocyte recruitment play a major role in the extension of myocardial damages after I/R [ 4 Yellon D.M. Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med. 2007; 357: 1121-1135 Crossref PubMed Scopus (2784) Google Scholar , 5 Steffens S. Montecucco F. Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion. Thromb Haemost. 2009; 102: 240-247 PubMed Google Scholar ]. Rapidly after the restoration of blood flow, leukocytes infiltrate into the myocardium in response to complement activation and massive release of reactive oxygen species (ROS) [ 4 Yellon D.M. Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med. 2007; 357: 1121-1135 Crossref PubMed Scopus (2784) Google Scholar , 5 Steffens S. Montecucco F. Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion. Thromb Haemost. 2009; 102: 240-247 PubMed Google Scholar ]. Neutrophils, monocytes and lymphocytes are the principal immune cells implicated in this process [ [6] Dewald O. Ren G. Duerr G.D. et al. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol. 2004; 164: 665-677 Abstract Full Text Full Text PDF PubMed Google Scholar ]. Once recruited into the tissue, inflammatory cells release proteolytic enzymes and ROS that contribute to the development of injuries. These indicated that inflammation plays a critical role in myocardial I/R injury.